We have previously found that for permeabilized L1210 cells, low micromolar concentrations of Ins(1,3,4,5)P % added prior to Ins(2,4,5)P $ enhance the effects of suboptimal concentrations of Ins(2,4,5)P $ in causing Ca# + release from InsP $ -sensitive Ca# + stores [Cullen, Irvine and Dawson (1990) Biochem. J. 271, [549][550][551][552][553]. If this was due either to some conversion of added Ins(1,3,4,5)P % into Ins(1,4,5)P $ by the 3-phosphatase, or to Ins(1,3,4,5)P % acting as a weak (or partial) agonist on the InsP $ receptor it would be expected that, in the presence of thimerosal to sensitize the InsP $ receptor, the dose-response curve to Ins(1,3,4,5)P % would be left-shifted by the same extent as that of Ins(1,4,5)P $ . This was found not to be the case ; the dose-response curve to Ins(1,3,4,5)P % was not shifted at all by thimerosal.
INTRODUCTION
There has been controversy for several years about the physiological function of InsP % and whether or not it has a second messenger function in some aspect of the regulation of intracellular Ca# + movements [1, 2] . A very positive piece of evidence for a second messenger function has been the demonstration (reviewed in [3] ) of specific high-affinity InsP % -binding sites in a wide variety of neuronal and non-neuronal cells. We have recently purified to homogeneity a high-affinity InsP % -binding protein from pig platelets [4] which we have now shown has GTPaseactivating protein (GAP) activity and which we have suggested is named GAP1 IP%BP [5] . However, the function of such binding proteins, and the downstream effects of InsP % on cell signalling remain ill-defined.
Effects of InsP % on Ca# + signals have been observed in sea urchin eggs [6] , perfused lachrymal cells [7] [8] [9] and ras-transformed fibroblasts [10] . In the first two of these systems, synergy was observed between InsP % and InsP $ , suggesting that the presence of InsP $ was required in order to observe any effects of InsP % . A variety of other systems have also been shown to respond to InsP % (reviewed in [1] ) and, notably, an InsP % -sensitive Ca# + channel has been demonstrated in endothelial cells [11] . In permeabilized cells, and microsomal preparations, two effects have been seen. In permeabilized L1210 cells, we have found that there is a synergistic effect of InsP % in enhancing release of Ca# + by Ins(2,4,5)P $ [12] . A similar effect has been shown in pituitary microsomes [13] . In contrast, for permeabilized SH-SY5Y neuroblastoma cells, Gawler et al. [15, 16] We have adopted several experimental approaches in order to address this problem. As an experimental system, we have used L1210 cells which have been permeabilized either with digitonin or by electroporation using silver electrode plates. Neither of these treatments leads to activation of detectable inositol polyphosphate 3-phosphatase activity. As previously, we have used Ins(2,4,5)P $ as an InsP $ -receptor agonist since, unlike Ins(1,4,5)P $ , it cannot be converted into Ins(1,3,4,5)P % by the 3-kinase and is poorly metabolized by the 5-phosphatase [12] . We have attempted to make all measurements of the effects of InsP % as rapidly as possible (usually within 15 s) after the addition of InsP % to the experimental medium, to minimize the possibility of conversion of InsP % into Ins(1,4,5)P $ . Under these conditions we have compared the effect of thimerosal on the dose-response curves for InsP % and Ins(2,4,5)P $ . Thimerosal has been shown, in a variety of systems [22, 23] to sensitize the InsP $ receptor by shifting the dose-response curve by up to a factor of ten to the left. If InsP % were to work via the InsP $ receptor, then a similar shift in the dose-response curve of InsP % would be expected. We have also examined the effect of -Ins(1,3,4,5)P % , which has been shown to displace -Ins(1,3,4,5)P % from high-affinity binding sites [4, 19] but to be without effect on the binding of Ins (1, 
Cell growth
Mouse lymphoma L1210 cells were grown essentially as described previously [24] using a system of gas-permeable batch culture. Cells were grown over a 4 day period to a density of 6.0i10& cells\ml, as measured on a Coulter electronic cell counter. A 42 ml sample of cells (6.0i10& cells\ml) were centrifuged at 2000 g for 5 min in a bench centrifuge at 25 mC. The pellet was resuspended in 25 ml of wash buffer consisting of 0.9 % (w\v) NaCl, 20 mM Hepes\KOH, pH 7.0, at 30 mC and centrifuged as above. This wash was repeated before resuspending the final pellet of cells in 1 ml of assay buffer to give a cell density of 2.5i10( cells\ml.
Cell permeabilization
Permeabilization by electroporation was carried out with a BioRad Gene Pulser using a custom-designed electroporation cuvette. Cells were subjected to five pulses of 0.8 kV (2 kV\cm) with a capacitance of 25 µF and a time constant of 0.3 ms. Unlike commercially available electroporation cuvettes, the custom-designed cuvettes had electrode plates made from silver foil. This avoided possible artefacts shown to be due to solubilization of cations from the electrode plates [18] .
Permeabilization by digitonin was performed by adding 10 µg of digitonin (in 1 µl of DMSO) per ml of 2.5i10( cells suspended in the assay medium.
Ca 2 + uptake
To increase reproducibility between successive experiments, permeabilized cells were loaded with Ca# + on a large scale (10-15 ml of 2.5i10( cells\ml). The assay medium consisted of 100 mM KCl, 20 mM Hepes\KOH, pH 7.0, 1 mM dithiothreitol, 5 mM succinate (K + salt), 50 mg\ml creatine kinase, 10 mM phosphocreatine, 1 mM MgCl # , 0.7 mM ATP and 1 µM Fluo-3 (pentammonium salt). Experiments were carried out at 30 mC. Ca# + uptake was routinely measured with a Ca# + -sensitive electrode. Ca# + -sensitive membranes contained the neutral ionophore ETH1001 and were prepared by the method described by Clapper and Lee [25] . After the cells had loaded to steady state, 1 ml samples of the incubation mixture were transferred to a Shimadzu RF-5000 or Perkin-Elmer LS50B fluorimeter coupled to an IBM-compatible computer. Ca# + release was measured by Fluo-3 fluorimetry. The Ca# + release properties of the cells loaded in large scale were constant for up to 2 h, allowing experiments to be carried out in rapid succession on identical 1 ml samples of cells.
Under the experimental conditions described above, the InsP $ -sensitive pool was 76p3 % (n l 10) of the total ionomycinreleasable Ca# + pool.
Kinetic analysis
Digitized output from the fluorimeter was processed first by Microsoft Excel. The time course of Ca# + efflux was found to fit to a double-exponential function. Enzfitter (Biosoft) was used to determine rate constants and extents for fast and slow phases of Ca# + release.
Immunoblotting of InsP 4 -binding protein
Immunological identification of the specific InsP % -binding protein in L1210 cells was carried out using a polyclonal rabbit antibody raised against a C-terminal peptide of human GAP1 IP%BP [5] . After SDS\PAGE and electroblotting on to poly(vinylidene difluoride) membranes, blots were probed with anti-GAP1 IP%BP antibody at a dilution of 1 : 4000 (or rabbit pre-immune serum), followed by peroxidase-conjugated goat anti-(rabbit IgG) secondary antibody (Dako). The blot was developed using enhanced chemiluminescence detection reagents (Amersham) and exposure to X-ray film. Figure 1 shows the experimental protocol used to measure the dose-response characteristics of Ins(2,4,5)P $ and Ins(1,3,4,5)P % . The data shown in Figure 1 were from electroporated cells, but similar data were also obtained from cells permeabilized with digitonin. Under these conditions, low doses of Ins(2,4,5)P $ cause a biphasic release of Ca# + , similar to that described by Meyer and Stryer [26] . Ins(1,3,4,5)P % causes no Ca# + release by itself (Figure 1 ) even after 8 min (results not shown) but, as previously found [12] , increases the response to Ins(2,4,5)P $ added 5 s after InsP % . Typically, Ins(1,3,4,5)P % does not change the magnitude of the fast phase of Ca# + release, but increases the size of the slow phase (Table 1 and see also the traces in Figures  5 and 6 ). As found previously [12] , the effect of Ins(1,3,4,5)P % on the extent of Ca# + release is only readily observable at Ins(2,4,5)P $ concentrations which cause mobilization of 50 % or less of the total InsP $ -sensitive pool. To quantify the effect of Ins(1,3,4,5)P % , the rate of Ca# + release was measured 10 s after the addition of Ins(2,4,5)P $ , to avoid complications due to effects of mixing and the fast phase of release. The rates taken are shown as dotted lines in Figure 1 . Also illustrated in Figure 1 is the ' order of addition ' phenomenon observed previously [12] , where addition of InsP % after InsP $ is without effect. Application of 100 µM thimerosal to the incubation mixture results in sensitization of the InsP $ receptor [22, 23] and, in these cells, the dose-response curve for Ins(2,4,5)P $ is shifted about 4-fold to the left (Figure 2A) . The resultant EC &! values are approx. 0.4 µM and 1.6 µM in the presence and absence of thimerosal respectively. Thimerosal causes a complementary leftward shift of the dose-response curve to Ins(2,4,5)P $ when the latter is expressed in terms of the initial rate of Ca# + release in the slow phase ( Figure 2B ). Incubation of cells for up to 4 min with thimerosal alone caused no Ca# + release, suggesting that production of endogenous Ins(1,4,5)P $ is very small (cf. [27] ). Routinely, thimerosal was added 1 min before Ins(2,4,5)P $ . In order to compare the dose-response to InsP % under conditions where Ca# + release was similar, it was necessary to adjust the concentration of Ins(2,4,5)P $ to give similar control Ca# + release. By decreasing the Ins(2,4,5)P $ from 1 µM to 0.25 µM while maintaining the InsP % concentration at 2 µM, in the presence of thimerosal, a set of Ca# + release traces superimposable on those shown in Figure 1 were obtained. The effect of InsP % concentration on the rate of Ca# + release, measured as indicated above and in Figure 1 , in the presence and absence of thimerosal, is shown in Figure 3 . It is clear that the concentration dependence of the effect of InsP % is unaffected by the presence of thimerosal, the EC &! being about 1.2 µM under both conditions. Wilcox et al. [19] have shown that -Ins(1,3,4,5)P % [equals -Ins(1,3,5,6)P % ] displaces [$#P]-Ins(1,3,4,5)P % from specific binding sites on pig cerebellar membranes with a potency only 10-fold less than -Ins(1,3,4,5)P % , while it was 1000-fold weaker than Ins(1,4,5)P $ at displacing [$H]Ins(1,4,5)P $ from specific InsP $ -binding sites. We have found a similar displacement of -Ins(1,3,4,5)P % by -Ins(1,3,4,5)P % from a putative InsP % receptor (GAP1 IP%BP ) purified from pig platelets [4] . Using permeabilized SH-SY5Y cells, Wilcox et al. [19] , showed that while - Results from progress curves were fitted using Enzfitter to two exponentials. InsP 4 had no effect on the rate constant or extent of the initial fast phase of Ca 2 + release. The parameters for the slow phase in the presence of 2 µM Ins(1,3,4,5)P 4 were expressed as a percentage of the paired value for the given concentration of Ins(2,4,5)P 3 in the absence of Ins(1,3,4,5)P 4 (pS.E.M.). n is the number of separate batches of cells used for each data set. release from electroporated cells Assay conditions were as described for Figure 1 . In (A), Ins(2,4,5)P 3 -induced Ca 2 + release was expressed as a percentage of the Ca 2 + release caused by a supramaximal Ins(2,4,5)P 3 concentration (16 µM). In (B), the initial rate of the slow phase of Ins(2,4,5)P 3 -induced Ca 2 + release was measured as described in Figure 1 . The effect of thimerosal on the dosedependence of Ins(2,4,5)P 3 -stimulated Ca 2 + release was measured at 0 µM (#) and 100 µM ($) thimerosal. Experiments were carried out in triplicate at 30 mC.
RESULTS AND DISCUSSION
Ins(1,3,4,5)P % would release Ca# + from intracellular stores, the -isomer was essentially inactive at concentrations of less than 100 µM, thus supporting their interpretation that in their cells Ins(1,3,4,5)P % is indeed acting as a direct agonist on Ins(1,4,5)P $ receptors. Measurement of binding of inositol phosphates to sonicated membranes from L1210 cells has proved difficult, due to the presence of high levels of non-specific binding. However, immunoblotting (Figure 4) shows that the antibody against the C-terminal sequence of human GAP1 IP%BP recognizes a very similar protein in L1210 cells. There is an intensely stained band migrating at approx. 100 kDa (cf. human platelets). The two weaker bands at lower molecular masses are due to low-affinity reactions with very abundant proteins. It is thus likely that L1210 cells contain a mouse equivalent of GAP1 IP%BP and hence that -Ins(1,3,4,5)P % will be able to displace -Ins(1,3,4,5)P % from its specific binding sites. Figure 5 shows the effect of 40 µM -Ins(1,3,4,5)P % on Ca# + release from permeabilized L1210 cells. Under these conditions, 40 µM -Ins(1,3,4,5)P % is capable of mimicking the effect of 2 µM -Ins(1,3,4,5)P % in enhancing the action of Ins(2,4,5)P $ , consistent with the approx. 10-fold higher K d found for the -isomer compared with -Ins(1,3,4,5)P % [4, 19] . 
